Jove
Visualize
联系我们

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

284
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
284

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A Double Jeopardy: Thrombotic Thrombocytopenic Purpura in Systemic Mastocytosis-A Rare but Lethal Conundrum.

International journal of laboratory hematology·2026
Same author

Images in Vascular Medicine: Beyond the lesion - recognizing hematologic sequelae of venous malformations.

Vascular medicine (London, England)·2026
Same author

Pancreatic Plasmacytoma Post-Allogeneic-HSCT: Diagnosis by EUS-Guided Biopsy.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion·2026
Same author

Infection-related mortality after hematopoietic stem cell transplantation in a high antimicrobial resistance setting.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2026
Same author

Allogeneic Hematopoietic Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma: A Multicenter Real-World Experience

Turkish journal of haematology : official journal of Turkish Society of Haematology·2026
Same author

Exploring an independent association between rituximab-cyclophosphamide-doxorubicin-vincristine-prednisolone dose intensity and clinical outcomes in large B-cell lymphoma: Analyses of subsequent endpoints following a complete response in a real-world cohort of 1369 patients.

Cancer·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jun 6, 2025

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.2K

如何改善AML的结果?

Taner Tan1, Sinem Civriz Bozdag2

  • 1Department of Hematology, ͣKoc University Medical School, Istanbul, Turkey.

Blood research
|December 2, 2024
PubMed
概括

了解急性髓性白血病 (AML) 病理生理学和基因组学的进步正在导致超出标准7+3方案的新疗法. 最近的分类强调了AML.

科学领域:

  • 血液学 血液学 血液学
  • 在瘤学瘤学.
  • 遗传学 是一个遗传学.

背景情况:

  • 自20世纪70年代以来,急性髓性白血病 (AML) 治疗一直以7+3疗法为主.
  • 了解AML病理生理学和基因组景观的最新进展正在改善患者的治疗结果.
  • 2022年世界卫生组织和国际共识分类更新反映了AML定义的分子级变化.

研究的目的:

  • 以突出基于分子和遗传特征的急性髓性白血病 (AML) 的不断发展的理解.
  • 为了强调转向基因定义的AML分类的转变.
  • 将超越传统化疗的新型治疗策略的发展置于背景.

主要方法:

  • 对急性髓性白血病 (AML) 的当前文献和分类指南的审查.
  • 分析分子分析对AML理解和治疗的影响.
  • 关于AML患者驱动突变的回顾性研究数据.

主要成果:

  • 现在,急性髓性白血病 (AML) 被认为是一种遗传多样性的疾病.
  • 一项回顾性研究确定了76个基因/基因组区域中的5234个驱动突变.
  • 86%的AML患者表现出两个或两个以上的驱动突变,强调遗传异质性.
关键词:
在AML,AML就是AML.突变 突变 突变 突变 突变结果结果的结果.复发的 复发的 复发的有针对性的有针对性的有针对性的有针对性的治疗方法 治疗方法

更多相关视频

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

13.9K
Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

1.8K

相关实验视频

Last Updated: Jun 6, 2025

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.2K
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

13.9K
Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

1.8K

结论:

  • 现代AML分类越来越依赖于遗传特征.
  • 新的分子标正在推动AML的新治疗策略的开发.
  • 对AML基因组学的不断发展的理解需要超越历史治疗范式.